0

Xstrahl Focuses on Innovation at ASTRO 2019

Xstrahl would like to invite you to explore several new treatment and preclinical research advancements at the annual ASTRO meeting on September 15th-18th in Chicago. Xstrahl is launching a new [...]

0

Xstrahl In Action: Xstrahl 200 Used for Treatment of Advanced and Inoperable Bowen’s Disease

Bowen’s disease is a type of squamous cell carcinoma (SCC) in situ of the skin usually characterized by slow-growing, red and scaly patches of skin. Bowen’s disease can be symptomatic and can [...]

0

Xstrahl In Action: SARRP used in evaluation of four different small animal radiation plans on tumour and normal tissue dosimetry

Small animal radiotherapy research platforms such as Xstrahl’s SARRP enable more precise irradiation of tumours and normal tissues in pre-clinical models of cancer.   In their study [...]

0

Xstrahl In Action: SARRP Used for Research into Leukocyte Populations After Intestinal Irradiation

In their paper “Interleukin 6 Signaling Blockade Exacerbates Acute and Late Injury From Focal Intestinal Irradiation” Bell BI, Koduri S, Salas Salinas C, et al, aim to evaluate the acute changes [...]

0

Xstrahl Invites You to See the Next Evolution in Preclinical Research Platforms at ICRR 2019

Xstrahl Life Science is attending the 16th annual International Congress for Radiation Research, ICRR 2019 on the 25th -29th August in Manchester, UK, and would like to invite you to experience [...]

0

ÖGRO – 35. Jahrestagung 2018

8 – 9 November 2019 (Vienna, Austria)

0

Xstrahl In Action: SARRP Used for Research into Mebendazole Use for Malignant Meningiomas

Meningiomas are a frequent tumor of the central nervous system. Although mostly benign, approximately 5% present as atypical or malignant tumors. Treatments for atypical meningiomas include gross [...]

0

RRS Annual Meeting 2019

3 – 6 November 2019 (San Diego, USA)